Antibiotic use for children in the PICU with severe viral bronchiolitis
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Children with severe
bronchiolitis are admitted to the
PICU, and often receive empiric
antibiotics. However,
viral bronchiolitis is not treated
with antibiotics, but with
supportive care. Antibiotics
may be used for secondary
bacterial pneumonia, which is
difficult to diagnose in small
children. The initiation of
antibiotics for this viral illness
lacks evidence or consistency
amongst physicians.

OBJECTIVES: To examine clinical factors associated with systemic antibiotic use in severe
bronchiolitis based on retrospective chart review of PICU patients.
METHODS: We identified children discharged from the UNMH PICU from
January 2017-January 2019 diagnosed with severe viral bronchiolitis. Variables
extracted included demographics, treatments, lab values and outcomes. Stata/SE 15.1
was used to calculate descriptive statistics and to examine relationships between clinical
factors and antibiotic administration using a t-test, Pearson’s chi-square test or Fisher’s
exact test.
RESULTS: Children (n=208) were on average 11.3 ± 8.6 (SD) months old with a length
of stay of 10.8 ± 6.4 days. Seventy children (34%) received antibiotics. Fifteen children
(7%) had a definitive diagnosis of bacterial pneumonia (positive tracheal culture).
Children who received antibiotics were slightly younger than those who did not (average Text
age 10.3 vs. 11.9 months; p = 0.09). Fifty-four percent of children on a ventilator (n=26)
received antibiotics versus 31% of children who were not ventilated (p=0.02). Forty-one
percent of children with elevated temperature (≥38°C; n=115) received antibiotics vs
SETTING AND TEAM
24% of children with normal temperature (n=89; p=0.009). Seventy-two percent of children
with high CRP (>2 mg/L; n=18) received antibiotics versus 56% of children with normal
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CRP (n=18; p=0.24).
in the UNMH PICU. The QI team
CONCLUSIONS: In the UNMH PICU, a substantial proportion of children with severe
consists of one attending physician
viral bronchiolitis receive antibiotics without a definitive diagnosis of bacterial pneumonia.
and one research advisor.
These children were younger and sicker, with fever, elevated CRP and mechanical
Funding for preliminary data
ventilation. An evidence-based, expert opinion supported, clinical decision-making
collection was provided through an
algorithm is needed to better identify children that require systemic antibiotics in the
internal RAC grant through the
setting of severe viral bronchiolitis.
Dept of Pediatrics.
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QI Framework
IHI Model for Improvement:
http://www.ihi.org/resources/Pages/Ho
wtoImprove/default.aspx

To standardize the initiation of systemic antibiotics for the diagnosis of viral bronchiolitis
by demonstrating a 60% adherence to a clinical decision Making algorithm informed by
the results of the chart review done in the planning phase of this study, in one
bronchiolitis season (Jan – April).
QI Project Measures
Adherence to clinical decision making algorithm for eligible patients with the diagnosis of viral
bronchiolitis in the UNMH PICU, during the next bronchiolitis season (Jan to April 2022)
NEXT STEPS

1.Create a consensus based clinical decision making algorithm with all PICU attendings
2.Educate PICU residents on QI project and encourage asking to use algorithm on eligible
patients with viral bronchiolitis
3. In Jan 2022, prospectively apply the guideline as the first DO portion of the PDSA format.
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